SAGE: Sage Therapeutics Inc Price to Net Income Growth Ratio

Brandmark of Sage Therapeutics Inc (SAGE)

Weak operational momentum at Sage Therapeutics, Inc. (SAGE) due to R&D misses is weighing on cash flows. However, an asset-light strategy with pharmaceutical behemoths allows the company to scale high-margin sales without incurring plant costs. The PEG momentum indicator reflects valuation dynamics, where the parameter value equals 0.00. Revenues are based on the commercialization of therapies for patients with depression through insurance systems and pharmacies.

SAGE Sage Therapeutics Inc. Price/Earnings to Growth Multiple (07/04/2022 - 08/16/2025)

Analytical breakdowns for Sage Therapeutics (SAGE)

General company analysis:SAGE - Sage Therapeutics Inc
Brand item of sagerx.com

To build a high-quality portfolio, I utilize the PEG ratio, which correlates the market value of a business with its earnings growth, identifying undervalued assets when the value is below one. Analyzing the peg_co multiplier allows for an assessment of how effectively the market currently prices in the sales potential of Sage Therapeutics, Inc. (SAGE) innovative depression therapies into the current share price.

Competitors of Sage Therapeutics, Inc.

Growth-Adjusted Market Cap to Net Income Biogen Idec|Neurocrine Corp - Price/Earnings to Growth Multiple|regencellbioscience.com (RGC) - Price to Earnings Adjusted for Growth Rate|AXSM - Price/Earnings to Growth Ratio|ACAD (ACADIA Pharmaceuticals Inc.) - Growth-Adjusted P/E Ratio|Xenon Pharmaceuticals (XENE) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio VKTX|Price/Earnings to Growth Ratio Supernus|Price to Earnings Adjusted for Growth Rate catalystpharma.com CPRX|Price/Earnings to Growth Multiple DNLI (Denali Therapeutics Inc.)|HRMY - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Biohaven Ltd. BHVN|AMLX (Amylyx) - Market Cap to Earnings and Growth Ratio|Trevi Therapeutics Inc - PEG Multiple|Growth-Adjusted Payback Ratio PRAX (Praxis Precision Medicines)|AVXL: PEG Multiple|CBLL - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio prothena.com|Price/Earnings to Growth Multiple Alector (ALEC)|Price/Earnings to Growth Multiple ANNX (annexonbio.com)|OMER - Price to Earnings Adjusted for Growth Rate|PEG Multiple NGNE (Neurogene Inc)|PEG Multiple AC Immune S.A. ACIU|VYGR - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMRA|SCLX (Scilex Holding Company) - Price/Earnings to Growth Multiple|TVGN (Tevogen Bio Holdings) - Price/Earnings to Growth Ratio|ACOG (Alpha Cognition Corp) - PEG Multiple|Cognition Therapeutics, Inc. - Market Cap to Earnings and Growth Ratio|PEG Multiple IKT|SAVA (Cassava) - Growth-Adjusted Payback Ratio|Assertio Holdings, Inc. - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio COYA|VistaGen Therapeutics, Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Ovid Therapeutics OVID|ABOS: PEG Multiple|CervoMed Corporation (CRVO) - PEG Multiple|Price/Earnings to Growth Ratio Alterity Therapeutics Limited|Price/Earnings to Growth Ratio CLNN|PEG Multiple PEPG|JUNS (Jupiter Neurosciences) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Relmada Corp RLMD|PEG Multiple Annovis Bio Corporation ANVS|gracetx.com - PEG Multiple|Firefly Neuroscience, Inc (AIFF) - Price/Earnings to Growth Multiple|Klotho Neurosciences (KLTO) - Price/Earnings to Growth Ratio|NeuroSense Therapeutics, Ltd. - Growth-Adjusted Payback Ratio|RVPH (Reviva Pharmaceuticals Holdings) - PEG Multiple|MetaVia Inc (MTVA) - Growth-Adjusted Market Cap to Net Income|PEG Multiple NRXS|Growth-Adjusted Market Cap to Net Income Helius Medical Technologies Inc.|Price/Earnings to Growth Ratio passagebio.com PASG|NEUP: Growth-Adjusted P/E Ratio|NERV - Price/Earnings to Growth Ratio|Athira - Company Value to Earnings Growth Ratio|ADXN: PEG Multiple|ALZN (Alzamend Neuro, Inc.) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Ratio Cyclerion Therapeutics Inc.|PTIX: Growth-Adjusted Payback Ratio|PEG Multiple KTTA|Company Value to Earnings Growth Ratio CRGT|Avenue Therapeutics Inc - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio BCLI|CARA - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio CHRO (Chromocell Therapeutics Corp)|ELYM: PEG Multiple|Growth-Adjusted P/E Ratio ITCI|Price/Earnings to Growth Ratio Longboard Pharmaceuticals Inc|marinuspharma.com (MRNS) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple NKGN (NKGen Biotech, Inc.)|NRBO - Price to Earnings Adjusted for Growth Rate|Synaptogenix, Inc. - Price/Earnings to Growth Multiple|TRVN: Growth-Adjusted P/E Ratio|VIGL - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio WENA (Anew Medical, Inc.)|CERE: PEG Multiple